On February 5, 2010
Analyst Rips Pfizer a New One Over $1.5B Guidance Discrepancy
The reaction to Pfizer (PFE)’s Q4 2009 earnings call — in which the company dialed back its 2012 revenue guidance to $1.5 billion less than it promised at the time of its merger with Wyeth — didn’t stop after sellers
…
0 Comments